Alanyl‑glutamine prophylactically protects against lipopolysaccharide‑induced acute lung injury by enhancing the expression of HSP70

Wang,Haitang; Dong,Yinv; Cai,Yehua

doi:10.3892/mmr.2017.6896

Alanyl‑glutamine prophylactically protects against lipopolysaccharide‑induced acute lung injury by enhancing the expression of HSP70

Authors:
- Haitang Wang
- Yinv Dong
- Yehua Cai
View Affiliations

Affiliations: Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, P.R. China
Published online on: June 30, 2017 https://doi.org/10.3892/mmr.2017.6896
Pages: 2807-2813

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

At present, the timing of glutamine administration remains controversial. The aim of the present study was to confirm the early protective mechanisms of alanyl‑glutamine (Ala‑Gln) against lipopolysaccharide (LPS)‑induced lung injury, as well as to detect the best time for Ala‑Gln usage. A total of 60 adult Wistar rats were randomly divided into 6 groups: The control group (C), the LPS‑induced shock group (LPS), the pre‑Ala‑Gln treated group (A1) and the pre‑Gln treated group (G1), which separately received 4.5% Dipeptiven and 3% glutamine just before LPS administration; the post‑Ala‑Gln treated group (A2) and the post‑Gln treated group (G2), which was respectively infused with 4.5% Dipeptiven and 3% glutamine at 1 h following LPS. Survival rates were observed at 6 h following the LPS injection. Blood samples were drawn for analysis of cytokine levels 1 h prior to (T0) and 6 h following (T1) LPS injection. All rats were killed at T1 and the pulmonary samples were collected. Plasma concentrations of tumor necrosis factor‑α, interleukin (IL)‑1β and IL‑8 at T0 and T1, apoptosis in lung epithelial cells and the expression of heat shock protein (HSP)70 were detected. The lung wet/dry weight ratio (W/D) and the content of protein in the bronchoalveolar lavage fluid (BALF) were also determined. Survival rates at 6 h following (T1) LPS administration were both 100% in groups A1 and G2, but 70% in A2 and G2 groups. The W/D, the content of protein in BALF and cytokine levels were significantly lower in groups A1 and G1 than that in group LPS (P<0.05) at T1. The apoptosis index of both alveolar and bronchial epithelial cells was obviously lower in A1 and G1 groups than that in the LPS group (P<0.05). Gray gradients of HSP70 in the A1 and G1 groups were dramatically higher than those of group LPS (P<0.05). In conclusion, pre‑administration of Ala‑Gln just before LPS can effectively protect the lung by enhancing HSP70 expression, but delayed administration cannot protect LPS‑induced lung injury.

View Figures

View References

1	Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A and Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 149:818–824. 1994. View Article : Google Scholar : PubMed/NCBI
2	Margulis BA, Sandler S, Eizirik DL, Welsh N and Welsh M: Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1 beta-induced impaired beta-cell function. Diabetes. 40:1418–1422. 1991. View Article : Google Scholar : PubMed/NCBI
3	White DJ, Carlson D, Ordway GA and Horton JW: Protective role of heat stress in burn trauma. Crit Care Med. 32:1338–1345. 2004. View Article : Google Scholar : PubMed/NCBI
4	Wischmeyer PE, Kahana M, Wolfson R, Ren H, Musch MM and Chang EB: Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol (1985). 90:2403–2410. 2001.PubMed/NCBI
5	Jing L, Wu Q and Wang F: Glutamine induces heat-shock protein and protects against Escherichia coli lipopolysaccharide-induced vascular hyporeactivity in rats. Crit Care. 11:R342007. View Article : Google Scholar : PubMed/NCBI
6	Oliveira GP, Oliveira MB, Santos RS, Lima LD, Dias CM, Saber AM Ab', Teodoro WR, Capelozzi VL, Gomes RN, Bozza PT, et al: Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis. Crit Care. 13:R742009. View Article : Google Scholar : PubMed/NCBI
7	Singleton KD, Beckey VE and Wischmeyer PE: Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock. 24:583–589. 2005. View Article : Google Scholar : PubMed/NCBI
8	Singleton KD and Wischmeyer PE: Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression. Am J Physiol Regul Integr Comp Physiol. 292:R1839–R1845. 2007. View Article : Google Scholar : PubMed/NCBI
9	Singleton KD, Serkova N, Beckey VE and Wischmeyer PE: Glutamine attenuates lung injury and improves survival after sepsis: Role of enhanced heat shock protein expression. Crit Care Med. 33:1206–1213. 2005. View Article : Google Scholar : PubMed/NCBI
10	Singleton KD and Wischmeyer PE: Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia. Shock. 25:295–299. 2006. View Article : Google Scholar : PubMed/NCBI
11	Hayashi Y, Sawa Y, Fukuyama N, Nakazawa H and Matsuda H: Preoperative glutamine administration induces heat-shock protein 70 expression and attenuates cardiopulmonary bypass-induced inflammatory response by regulating nitric oxide synthase activity. Circulation. 106:2601–2607. 2002. View Article : Google Scholar : PubMed/NCBI
12	Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG, et al: Canadian Critical Care Trials Group: A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 368:1489–1497. 2013. View Article : Google Scholar : PubMed/NCBI
13	Kristof AS, Goldberg P, Laubach V and Hussain SN: Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med. 158:1883–1889. 1998. View Article : Google Scholar : PubMed/NCBI
14	Sun D, Chen D, Du B and Pan J: Heat shock response inhibits NF-kappaB activation and cytokine production in murine Kupffer cells. J Surg Res. 129:114–121. 2005. View Article : Google Scholar : PubMed/NCBI
15	Malhotra V and Wong HR: Interactions between the heat shock response and the nuclear factor-kappaB signaling pathway. Crit Care Med. 30:(1 Supp). S89–S95. 2002. View Article : Google Scholar
16	Chu EK, Ribeiro SP and Slutsky AS: Heat stress increases survival rates in lipopolysaccharide-stimulated rats. Crit Care Med. 25:1727–1732. 1997. View Article : Google Scholar : PubMed/NCBI
17	DeMeester SL, Buchman TG and Cobb JP: The heat shock paradox: Does NF-kappaB determine cell fate? FASEB J. 15:270–274. 2001. View Article : Google Scholar : PubMed/NCBI
18	Bai T, Sun YH and Wang JK: Effect of glutamine administered at different times on endotoxin-induced acute lung injury in rats. J China Med Univ. 36:418–420. 2007.
19	Kaplan J, Nowell M, Chima R and Zingarelli B: Pioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis. Innate Immun. 20:519–528. 2014. View Article : Google Scholar : PubMed/NCBI
20	Scharte M, Baba HA, Van Aken H, Schulzki C, Meyer J, Goeters C and Bone HG: Alanyl-glutamine dipeptide does not affect hemodynamics despite a greater increase in myocardial heat shock protein 72 immunoreactivity in endotoxemic sheep. J Nutr. 131:1433–1437. 2001.PubMed/NCBI
21	Bonet A and Grau T: Glutamine, an almost essential amino acid in critically ill patient. Med Intensiva. 31:402–406. 2007.(In Spanish). View Article : Google Scholar : PubMed/NCBI
22	Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, et al: Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature. 410:549–554. 2001. View Article : Google Scholar : PubMed/NCBI
23	Ahmad S, White CW, Chang LY, Schneider BK and Allen CB: Glutamine protects mitochondrial structure and function in oxygen toxicity. Am J Physiol Lung Cell Mol Physiol. 280:L779–L791. 2001.PubMed/NCBI
24	Roth E, Oehler R, Manhart N, Exner R, Wessner B, Strasser E and Spittler A: Regulative potential of glutamine-relation to glutathione metabolism. Nutrition. 18:217–221. 2002. View Article : Google Scholar : PubMed/NCBI
25	Armeni T, Ghiselli R, Balercia G, Goffi L, Jassem W, Saba V and Principato G: Glutathione and ultrastructural changes in inflow occlusion of rat liver. J Surg Res. 88:207–214. 2000. View Article : Google Scholar : PubMed/NCBI
26	Tritsch GL and More GE: Spontaneous decomposition of glutamine in cell culture media. Exp Cell Res. 28:360–364. 1962. View Article : Google Scholar : PubMed/NCBI
27	Yamamoto Y, Kume M and Yamaoka Y: Implications of heat shock proteins during liver surgery and liver perfusion. Recent Results Cancer Res. 147:157–172. 1998. View Article : Google Scholar : PubMed/NCBI